Search results for alzheimer's

“Furthermore, in rodent models of Alzheimer's disease, SIRT1 activation with resveratrol or via genetic overexpression reduces amyloid plaque formation and consequently delays neurodegeneration and cognitive decline.”

“A recent study found that oral diseases associated with tooth loss more than tripled the risk of developing Alzheimer's disease. Researchers assessed Alzheimer's disease risk among more than 32 million people.”

“Findings from a new study suggest that inadequate sleep increases a person's risk of developing Alzheimer's disease and dementia. Alzheimer's disease and dementia are age-related disorders characterized by memory loss, cognitive decline, and behavioral changes.”

“Abnormal aggregates of tau, a protein found in the brain, are one of the defining characteristics of Alzheimer’s disease. These aggregates, known as tau tangles, inhibit normal brain function. The degree of cognitive impairment in Alzheimer’s disease is correlated with their presence.”

“Alzheimer's disease is a neurodegenerative disorder characterized by progressive memory loss, spatial disorientation, cognitive dysfunction, and behavioral changes. It is the most common form of dementia, affecting nearly 50 million people worldwide.”

“A recent study found that a nasal spray that delivered neural stem cell extracellular vesicles—tiny particles that carry proteins and genetic material—reduced inflammation and improved brain function in a mouse model of Alzheimer’s disease, offering a safer, less risky approach.”

“Higher levels of these prions in human brain samples were also associated with early-onset forms of Alzheimer's disease and younger age at death. The study was published in Science Translational Medicine. This UCSF press release does a great job at summarizing the study.”

“Alzheimer’s disease is a neurodegenerative disorder characterized by progressive memory loss and cognitive decline. The primary risk factor for Alzheimer's disease is aging, with risk roughly doubling every five years after the age of 65 years.”

“In a study of 25 people diagnosed with mild to moderate dementia, 10 milligrams of oral NADH taken daily for three months elicited no evidence of cognitive improvement among the study participants. In a separate study, however, 12 patients diagnosed with Alzheimer's disease received 10 milligrams of NADH daily for six months.”

“Related studies have found that oral bacteria colonize the brain and release toxins that disrupt the blood-brain barrier, impairing its function and increasing the risk of Alzheimer's disease.”